Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 521-35-7
2. Cannabinolo [dcit]
3. Cannabinolum [inn-latin]
4. 6,6,9-trimethyl-3-pentylbenzo[c]chromen-1-ol
5. 6,6,9-trimethyl-3-pentyl-6h-dibenzo(b,d)pyran-1-ol
6. 3-amyl-1-hydroxy-6,6,9-trimethyl-6h-dibenzo(b,d)pyran
7. 6h-dibenzo(b,d)pyran-1-ol, 6,6,9-trimethyl-3-pentyl-
8. 7uyp6mc9gh
9. Nsc-134455
10. 6,6,9-trimethyl-3-pentyl-6h-benzo[c]chromen-1-ol
11. 6,6,9-trimethyl-3-pentyl-6h-dibenzo[b,d]pyran-1-ol
12. Chembl74415
13. Chebi:3360
14. 3-amyl-1-hydroxy-6,6,9-trimethyl-6h-dibenzo[b,d]pyran
15. 6h-dibenzo[b,d]pyran-1-ol, 6,6,9-trimethyl-3-pentyl-
16. Ncgc00168261-01
17. Cannabinolo
18. Cannabinolum
19. Cannabinol [inn:ban]
20. Cannabinol (cbn)
21. Nsc 134455
22. Unii-7uyp6mc9gh
23. Brn 0237145
24. Cannabinol (6ci)
25. Cannabinol [mi]
26. Cannabinol [inn]
27. Cannabinol [who-dd]
28. Dsstox_cid_28922
29. Dsstox_rid_83188
30. Dsstox_gsid_48996
31. Gtpl740
32. 5-17-04-00567 (beilstein Handbook Reference)
33. Divk1c_000972
34. Schembl121085
35. Cannabinol, Analytical Standard
36. Dtxsid3048996
37. Hms503c05
38. Kbio1_000972
39. Ninds_000972
40. Cannabinol 1.0 Mg/ml In Methanol
41. Zinc1530833
42. Tox21_113486
43. Bdbm50061117
44. Lmpk13120002
45. Nsc134455
46. Akos024457448
47. Db14737
48. 6,6,9-trimethyl-3-pentyl-6h-dibenzo(b,d)pyran-1-ol. Product Derived From Cannabis Sativa
49. Idi1_000972
50. Cas-521-35-7
51. 6h-dibenzo[b, 6,6,9-trimethyl-3-pentyl-
52. Cannabinol (cbn) 100 Microg/ml In Methanol
53. C07580
54. Cannabinol (cbn) 1000 Microg/ml In Methanol
55. Cannabinol (cbn) 250 Microg/ml In Acetonitrile
56. A934070
57. L000158
58. Q265831
59. Wln: T B666 Ho Ihj Cq E5 I1 I1 M1
60. 6,9-trimethyl-3-pentyl-6h-dibenzo[b,d]pyran-1-ol
61. 3-amyl-1-hydroxy-6,9-trimethyl-6h-dibenzo[b,d]pyran
62. 6,6,9-trimethyl-3-pentyl-6h-benzo[c]chromen-1-ol #
63. 6,6,9-trimethyl-3-pentyl-6h-benzo[c]chromen-1-ol(cannabinol)
64. 6,6,9-trimethyl-3-pentyl-6h-benzo[c]chromen-1-ol (cannabinol)
65. 6h-dibenzo[b,d]pyran-1-ol, 6,6,9-trimethyl-3-pentyl- (7ci,8ci,9ci)
66. Cannabinol Solution, 1.0 Mg/ml In Methanol, Ampule Of 1 Ml, Certified Reference Material
67. Cannabinol Solution, 1.0 Mg/ml In Methanol, Analytical Standard, For Drug Analysis
| Molecular Weight | 310.4 g/mol |
|---|---|
| Molecular Formula | C21H26O2 |
| XLogP3 | 6.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 4 |
| Exact Mass | 310.193280068 g/mol |
| Monoisotopic Mass | 310.193280068 g/mol |
| Topological Polar Surface Area | 29.5 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 391 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Cannabinol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cannabinol, including repackagers and relabelers. The FDA regulates Cannabinol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cannabinol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cannabinol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cannabinol supplier is an individual or a company that provides Cannabinol active pharmaceutical ingredient (API) or Cannabinol finished formulations upon request. The Cannabinol suppliers may include Cannabinol API manufacturers, exporters, distributors and traders.
click here to find a list of Cannabinol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Cannabinol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cannabinol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cannabinol GMP manufacturer or Cannabinol GMP API supplier for your needs.
A Cannabinol CoA (Certificate of Analysis) is a formal document that attests to Cannabinol's compliance with Cannabinol specifications and serves as a tool for batch-level quality control.
Cannabinol CoA mostly includes findings from lab analyses of a specific batch. For each Cannabinol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cannabinol may be tested according to a variety of international standards, such as European Pharmacopoeia (Cannabinol EP), Cannabinol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cannabinol USP).
LOOKING FOR A SUPPLIER?
